Edaravone and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Edaravone (edaravone), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Riluzole, and have Amyotrophic lateral sclerosis.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Edaravone. It is created by eHealthMe based on reports of 695 people who have side effects when taking Edaravone from the FDA, and is updated regularly.

What is Edaravone?

Edaravone has active ingredients of edaravone. eHealthMe is studying from 695 Edaravone users. Check the latest studies of Edaravone.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,342 drugs and 1,659 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

695 people reported to have side effects when taking Edaravone.
Among them, 20 people (2.88%) have Dyspnea exacerbated.

Could Edaravone cause Dyspnea exacerbated?

Among these 20 people:

How long have people been on Edaravone when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Edaravone? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Dyspnea exacerbated when taking Edaravone? *

What are other drugs people take besides Edaravone? *

What are other side effects people have besides Dyspnea exacerbated? *

Weakness: 5 people, 25.00%
Fever: 3 people, 15.00%
Headache (pain in head): 2 people, 10.00%
Fatigue (feeling of tiredness): 2 people, 10.00%
Paleness (unusual lightness of skin colour): 2 people, 10.00%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 10.00%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 2 people, 10.00%
Gait Disturbance: 2 people, 10.00%
Confusional State: 2 people, 10.00%
Weight Decreased: 2 people, 10.00%

What are the existing conditions these people have? *

Amyotrophic Lateral Sclerosis (nervous system disease that attacks nerve cells called neurons in your brain and spinal cord): 14 people, 70.00%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 3 people, 15.00%
Fat Embolism (fat obstruction due to injury): 2 people, 10.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 1 person, 5.00%
Pneumonia: 1 person, 5.00%
Nerve Degeneration (weakness in functioning of nerve due to degeneration): 1 person, 5.00%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 1 person, 5.00%
Diabetes: 1 person, 5.00%
Cerebral Thrombosis (blood clot in brain): 1 person, 5.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Edaravone and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Edaravone:

Edaravone (695 reports)

Browse all side effects of Edaravone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,342 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,659 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on edaravone (the active ingredients of Edaravone) and Edaravone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.